ERIC THOMASON: Open Payments
NPI 1528425501 · WEBB CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115,077 in 268 payments from 10 companies in 2025. Trend: 2023 $72,387 · 2024 $114,607 · 2025 $115,077
Speaker / faculty: $76,792Consulting: $19,521Travel & lodging: $13,974Food & beverage: $4,790
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 167 | $74,951 |
| E.R. Squibb & Sons, L.L.C. | 67 | $34,400 |
| Alkermes, Inc. | 15 | $4,942 |
| Lundbeck LLC | 2 | $280 |
| Axsome Therapeutics, Inc. | 8 | $173 |
| Teva Pharmaceuticals USA, Inc. | 5 | $148 |
| Dexcom, Inc. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Braeburn Inc. | 1 | $14 |
Products named: REXULTI, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, LYBALVI, ARISTADA, Auvelity, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
